James Cleary, MD, PhD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Switch Maintenance in Pancreatic (NCT05419479) | James Cleary, MD, PhD | 2022-11-30 |
| Adavosertib and Gemcitabine in Advanced Pancreatic (NCT05212025) | James Cleary, MD, PhD | 2022-06-01 |
Track James Cleary, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.